Peptide-β2-microglobulin-MHC fusion molecules bind antigen-specific T cells and can be used for multivalent MHC-Ig complexes

被引:40
作者
Greten, TF
Korangy, F
Neumann, G
Wedemeyer, H
Schlote, K
Heller, A
Scheffer, S
Pardoll, DM
Garbe, AI
Schneck, JP
Manns, MP
机构
[1] Hannover Med Sch, Abt Gastroenterol & Hepatol Endokrinol, D-30655 Hannover, Germany
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
关键词
multimeric MHC; CD8+T cell;
D O I
10.1016/S0022-1759(02)00346-0
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Recombinant soluble MHC molecules are widely used for visualization, activation and inhibition of antigen-specific immune responses. Using a genetic approach, we have generated two novel peptide-beta2-microglobulin-MHC constructs. We have linked the MHC molecule with the peptide of interest, without limiting the recognition by the cognate TCR. This molecule can also be joined with the IgG heavy chain resulting in a dimeric MHC-Ig fusion protein. These molecules bind antigen-specific T cells with high specificity and sensitivity, therefore, providing a valuable tool for detection as well as enrichment of antigen-specific T cells. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:125 / 135
页数:11
相关论文
共 43 条
[1]
Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[2]
Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay [J].
Becker, C ;
Pohla, H ;
Frankenberger, B ;
Schüler, T ;
Assenmacher, M ;
Schendel, DJ ;
Blankenstein, T .
NATURE MEDICINE, 2001, 7 (10) :1159-1162
[3]
Brosterhus H, 1999, EUR J IMMUNOL, V29, P4053, DOI 10.1002/(SICI)1521-4141(199912)29:12<4053::AID-IMMU4053>3.3.CO
[4]
2-3
[5]
An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines [J].
Carruth, LM ;
Greten, TF ;
Murray, CE ;
Castro, MG ;
Crone, SN ;
Pavlat, W ;
Schneck, JP ;
Siliciano, RF .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (11) :1021-1034
[6]
A SOLUBLE DIVALENT CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE INHIBITS ALLOREACTIVE T-CELLS AT NANOMOLAR CONCENTRATIONS [J].
DALPORTO, J ;
JOHANSEN, TE ;
CATIPOVIC, B ;
PARFIIT, DJ ;
TUVESON, D ;
GETHER, U ;
KOZLOWSKI, S ;
FEARON, DT ;
SCHNECK, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6671-6675
[7]
Denkberg G, 2000, EUR J IMMUNOL, V30, P3522, DOI 10.1002/1521-4141(2000012)30:12<3522::AID-IMMU3522>3.0.CO
[8]
2-D
[9]
Increased TCR avidity after T cell activation: A mechanism for sensing low-density antigen [J].
Fahmy, TM ;
Bieler, JG ;
Edidin, M ;
Schneck, JP .
IMMUNITY, 2001, 14 (02) :135-143
[10]
HLA-A2-PEPTIDE COMPLEXES - REFOLDING AND CRYSTALLIZATION OF MOLECULES EXPRESSED IN ESCHERICHIA-COLI AND COMPLEXED WITH SINGLE ANTIGENIC PEPTIDES [J].
GARBOCZI, DN ;
HUNG, DT ;
WILEY, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3429-3433